Last reviewed · How we verify
avutometinib and sotorasib
avutometinib and sotorasib is a Small molecule drug developed by Verastem, Inc.. It is currently in Phase 1 development. Also known as: AMG 510, LUMAKRAS™, VS-6766.
At a glance
| Generic name | avutometinib and sotorasib |
|---|---|
| Also known as | AMG 510, LUMAKRAS™, VS-6766 |
| Sponsor | Verastem, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- avutometinib and sotorasib CI brief — competitive landscape report
- avutometinib and sotorasib updates RSS · CI watch RSS
- Verastem, Inc. portfolio CI
Frequently asked questions about avutometinib and sotorasib
What is avutometinib and sotorasib?
avutometinib and sotorasib is a Small molecule drug developed by Verastem, Inc..
Who makes avutometinib and sotorasib?
avutometinib and sotorasib is developed by Verastem, Inc. (see full Verastem, Inc. pipeline at /company/verastem-inc).
Is avutometinib and sotorasib also known as anything else?
avutometinib and sotorasib is also known as AMG 510, LUMAKRAS™, VS-6766.
What development phase is avutometinib and sotorasib in?
avutometinib and sotorasib is in Phase 1.
Related
- Manufacturer: Verastem, Inc. — full pipeline
- Also known as: AMG 510, LUMAKRAS™, VS-6766
- Compare: avutometinib and sotorasib vs similar drugs
- Pricing: avutometinib and sotorasib cost, discount & access